69477-71-0

Usage

InChI:InChI=1/C10H13NO2/c1-6-5-10(13)7(2)4-9(6)11-8(3)12/h4-5,13H,1-3H3,(H,11,12)

Upstream product

• 2593-53-5 2,5-dimethyl-p-benzoquinone 4-oxime 
• 3096-71-7 2,5-dimethyl-4-amino phenol 

Downstream Products

• 861296-03-9 (4-acetylamino-2,5-dimethyl-phenoxy)-acetic acid 
• 142874-38-2 4-Acetylamino-2,5-dimethyl-1-(2-methyl-2-propenyloxy)benzene 
• 1297597-12-6 4-amino-N-acetyl-6-bromo-2,5-dimethylphenol 
• 1297597-17-1 N-acetyl-6-bromo-2,5-dimethyl-1,4-benzoquinone monoimine 
• 861796-92-1 (4-amino-2,5-dimethyl-phenoxy)-acetic acid 
• 142874-44-0 4-Acetylamino-2,5-dimethyl-6-(2-methyl-2-propenyl)phenol 

Relevant academic research and scientific papers

Aminocoumaran derivatives, their production and use

A novel aminocoumaran derivatives of the general formula (I): STR1 wherein R1 and R2 are a hydrogen atom, an acyl group, an alkoxycarbonyl group, an aliphatic group or aromatic group; R3 R4 and R5 are an optionally acylated hydroxyl optionally substituted amino group, alkoxy group or aliphatic group, or two of R3, R4 and R5 may be linked together to form a carbocyclic group; R6 and R7 are an aliphatic group and at least one of them has a methylene group at the α-position; R8 and R9 are a hydrogen atom or an aliphatic group or aromatic group, or a salt thereof is useful for medicines for preventing and treating various diseases such as arterial schleosis, hepatopathy, cerebrovascular diseases and the like.